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Koch’s postulates dictate the use of experimental models to illustrate features of human
disease and provide evidence for a singular organism as the cause. The underlying
cause(s) of bacterial vaginosis (BV) has been debated in the literature for over half
a century. In 1955, it was first reported that a bacterium now known as Gardnerella
vaginalis may be the cause of a condition (BV) resulting in higher vaginal pH, thin
discharge, a fishy odor, and the presence of epithelial cells covered in bacteria. Here
we review contemporary and historical studies on BV with a focus on reports of
experimental infections in human or animal models using Gardnerella vaginalis. We
evaluate experimental evidence for the hypothesis that G. vaginalis is sufficient to trigger
clinical features of BV or relevant health complications associated with the condition.
Additionally, we evaluate in vivo models of co-infection employing G. vaginalis together
with other bacterial species to investigate evidence for the hypothesis that G. vaginalis
may encourage colonization or virulence of other potential pathogens. Together, these
studies paint a complex picture in which G. vaginalis has both direct and indirect roles
in the features, health complications, and co-infections associated with BV. We briefly
review the current taxonomic landscape and genetic diversity pertinent to Gardnerella
and note the limitations of sequence-based studies using different marker genes and
priming sites. Although much more study is needed to refine our understanding of
how BV develops and persists within the human host, applications of the experimental
aspects of Koch’s postulates have provided an important glimpse into some of the causal
relationships that may govern this condition in vivo.
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INTRODUCTION
Bacterial vaginosis (BV) is a dysbiosis—a condition of the vaginal
microbiome that has been associated with a wide variety of
adverse health outcomes. The condition is characterized by
low levels of “healthy” lactobacilli and overgrowth of diverse
bacteria from other taxonomic groups, including Gardnerella,
Atopobium, Mobiluncus, Prevotella, Bacteroides, Anaerococcus,
Peptostreptococcus, Sneathia, Leptotrichia, and members of the
class Clostridia, among others (Ravel et al., 2011; Srinivasan
et al., 2012). BV has been associated with higher risk of
sexually transmitted infections (Wiesenfeld et al., 2003; Brotman
et al., 2010; Van De Wijgert, 2017), urinary tract infections
(Harmanli et al., 2000; Hillebrand et al., 2002), post-surgical
complications (Watts et al., 1990), infertility (Spandorfer et al.,
2001), pregnancy losses (Ralph et al., 1999), preterm birth
(Svare et al., 2006), intrauterine (Di Paola et al., 2017; Ádám
et al., 2018) and intraamniotic infections (Silver et al., 1989),
as well as cervical infections, dysplasia, and cancer (Di Paola
et al., 2017; Laniewski et al., 2018; Brusselaers et al., 2019).
These conditions and health complications associated with BV
and its member bacteria can be caused not only by bacteria,
but also by eukaryotic (e.g., trichomoniasis) (Jarrett et al.,
2019) and viral (e.g., HIV, HSV, HPV) pathogens. In addition,
women with diverse BV-like microbiomes are more likely to
exhibit signs of genital inflammation (Lennard et al., 2017) and
vaginal colonization by other potential pathogens such as beta-
hemolytic streptococci (Cherpes et al., 2005) and Fusobacterium
nucleatum (Hillier et al., 1993; Hill, 1998; Hitti et al., 2001). BV is
characterized by reduced numbers of lactobacilli and overgrowth
of a polymicrobial consortium often containing large numbers
of Gardnerella vaginalis (Shipitsyna et al., 2013; Balashov et al.,
2014). Despite all of this, many/most women do not report
symptoms of BV to their providers, even in settings where the
clinical signs and/or inflammatory markers are evident (Masson
et al., 2019).
First reported as “Haemophilus vaginalis,” the organism now
known as Gardnerella vaginalis was reported to be the sole cause
of clinical signs and symptoms now used to diagnose BV (then
referred to as non-specific vaginitis, NSV) (Gardner and Dukes,
1954, 1955). However, controversies surrounding the clinical
significance of Gardnerella have abounded since its debut in the
literature in the 1950s. Today the pendulum has swung in the
opposite direction. While some believe that G. vaginalis may be
a sole causal contributor to BV (Schwebke et al., 2014b), others
have been skeptical of this and consider G. vaginalis to be one
of many within the BV consortium (Hickey and Forney, 2014;
Schwebke et al., 2014a). Recently, a more complex model has
been proposed, taking into account recent efforts to build animal
models for BV and arguing that relationships between multiple
microbes, including G. vaginalis, may underpin the condition
(Muzny et al., 2019a).
Here we review and consider the implications of
contemporary and historical findings from studies reporting
experimental infections in vivo usingGardnerella vaginalis. From
the early experimental studies in women, tomore recent attempts
to replicate clinical signs and associated health complications
of BV in small animal models, the existing studies paint a
complex picture that reflects the biology of the mammalian
vagina and the organisms that colonize it. In this review, we
will evaluate the evidence from experimental inoculations in
humans and other animals that G. vaginalis (on its own, or
together with other organisms) has a causal role in generating
features or complications that have been linked with BV. We
also review and discuss the interpretations of some of the
earlier experiments in light of our current appreciation about
Gardnerella and BV, specifically considering the genetic diversity
among Gardnerella strains (Ahmed et al., 2012; Janulaitiene
et al., 2018; Vaneechoutte et al., 2019).
HISTORICAL CONTEXT AND CURRENT
CONTROVERSIES
Originally the diagnostic term “non-specific vaginitis” (NSV)
was used to describe vaginal symptoms of unknown etiology,
but Gardner and Dukes suggested in the 1950’s that >90% of
NSV cases were caused by a single organism-G. vaginalis (Catlin,
1992). A substantial body of clinical literature links both NSV
(and as it later became known BV) to adverse health outcomes.
Although the term “vaginitis” suggests otherwise, NSV was not
typically associated with canonical signs of inflammation such
as redness or swelling. Even in the 1950s, Gardner and Dukes
realized that “argument may be advanced against calling this
infection an inflammatory disease as the term vaginitis implies;
however, it must continue to be included in this category until
such time as a more suitable term has been proposed and
accepted” (Gardner and Dukes, 1959). It would be decades
later before “bacterial vaginosis” (BV) started to be used in the
literature as a diagnostic term that more accurately represented
the condition in question. Around the time “BV” started to
be used, Amsel et al. outlined a set of clinical criteria, now
known as the Amsel criteria, to diagnose NSV (Amsel et al.,
1983). Today, the Amsel criteria is still used clinically for the
diagnosis of BV (C.f.D.C.a. Prevention, 2015). Three of four
of the following (Amsel) criteria are generally considered to
support the diagnosis of BV: (1) a thin, homogenous discharge,
(2) higher than normal pH (>4.5), (3) the presence of “clue”
cells in wet mount (epithelial cells that appeared to be coated in
bacteria), and (4) the detection of a fishy odor, with or without
treatment of the sample with 10% potassium hydroxide. BV can
also be diagnosed via the Nugent scoring method. Although high
interobserver variability of the Nugent score has been noted
in some studies (Forsum et al., 2008), it remains the current
gold standard for laboratory-based BV diagnosis used in clinical
research. First published by Nugent et al. (1991), this method
does not rely on clinical signs of BV, but instead uses Gram-
stained smears of vaginal fluid to evaluate the balance of bacterial
morphotypes present in the genital tract, resulting in a score from
0 to 10 (Nugent et al., 1991). A Nugent score of 0–3 indicates
a normal Lactobacillus-dominant microbiota, 4–6 indicates an
“intermediate microbiota,” and a score of 7–10 indicates BV
(Nugent et al., 1991; Amegashie et al., 2017).
Additional characteristics of BV include lower viscosity
vaginal fluids, a shift in fermentation products and other
metabolites, presence of the diamines putrescine and cadaverine,
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detectable levels of the enzyme sialidase and the liberation and
overall depletion of mucosal sialic acids (Briselden et al., 1992;
Catlin, 1992; McGregor et al., 1994; Olmsted et al., 2003; Lewis
et al., 2013; Chappell et al., 2014; Srinivasan et al., 2015; Nelson
et al., 2018). BV is still clinically considered a non-inflammatory
condition, as it is not typically associated with edema of vaginal
tissue (Mitchell and Marrazzo, 2014) nor increased numbers of
neutrophils in the cervicovaginal space (Giraldo et al., 2012).
However, several studies have reported increased levels of pro-
inflammatory cytokines such as IL-1β, IL-6, IL-8, and IP-10
(among others) in vaginal specimens from women with BV
as compared to “healthy” controls (Cauci et al., 2002, 2008;
Hemalatha et al., 2012). The apparent discrepancy between
clinical findings (lack of neutrophils/overt inflammation) is
not fully understood (Forsum et al., 2005). High resolution
studies evaluating relationships between chemokine/cytokines
and specific types of communities or member bacterial taxa
associated with BV have found that larger proportions of
Prevotella and other microbes were associated with a more
pro-inflammatory phenotype and increased risk of adverse
health outcomes (Anahtar et al., 2015; Gosmann et al., 2017;
Lennard et al., 2017; Shannon et al., 2017; Fettweis et al.,
2019). However, in general, high levels of neutrophils present
in vaginal secretions is indicative of other conditions such as
“desquamative inflammatory vaginitis” or “aerobic vaginitis”
(Donders et al., 2002; Mason and Winter, 2017). Finally, we
emphasize that not all cases BV are characterized by the
same signs/symptoms or the presence of clue cells and no
single species is a universal marker of BV (Srinivasan et al.,
2012).
Gardnerella vaginalis has had a long history of controversy
related to its taxonomy and clinical significance, some of which
continues to this day. Around the same time the organism was
isolated by Gardner and Dukes from the vaginas of women with
nonspecific vaginitis (NSV) (Gardner and Dukes, 1954, 1955),
it was also identified as a “Haemophilus-like” bacterium found
in patients with cervicitis and prostatitis (Leopold, 1953). These
first reports classified it as a Haemophilus species because they
found it negative by Gram staining and unable to grow on agar
without blood (Turovskiy et al., 2011). However, later studies
revealed that H. vaginalis did not require hemin or nicotinamide
adenine dinucleotide (NAD) for growth, making it clear that
the organism was not actually a member of the Haemophilus
genus. Additionally, the bacterium appeared to sometimes
have a positive Gram staining reaction. For these reasons H.
vaginalis was reassigned to the Corynebacterium genus, and
renamedCorynebacterium vaginale (Catlin, 1992). This name too
proved to be inaccurate, as unlike Corynebacterium species, the
bacterium was catalase negative and did not have arabinose in its
cell wall (Turovskiy et al., 2011). In 1980, two large taxonomic
studies used DNA-hybridization, electron microscopy, and a
variety of biochemical methods to show that the bacterium
lacked close similarity with any previously established genera
(Greenwood and Pickett, 1980; Piot et al., 1980; Catlin, 1992).
This lead to the proposal of a new genus, Gardnerella, and the
name Gardnerella vaginalis for the bacterium (Greenwood and
Pickett, 1980).
Despite early confusion about the taxonomy of what came
to be known as Gardnerella, Gardner and Dukes believed they
had found the sole etiological agent of most cases of NSV.
The 1955 paper reported that among the (Caucasian) women
from Gardner and Dukes gynecology practices, H. vaginalis
was isolated from the lower genital tract of 127 out of 138
women diagnosed with NSV (92%), but none of the 78 healthy
women examined. Gardner and Dukes argued that the vast
majority of NSV cases were really cases of H. vaginalis infection
(Gardner and Dukes, 1955). But, not long after H. vaginalis was
discovered as a potential causative agent of NSV, it became a
point of controversy. This topic remains controversial to this day,
with some recent studies using sensitive molecular techniques
suggesting that most women (including >60% without BV) have
Gardnerella colonizing the vagina, although women without BV
had ∼4 orders of magnitude lower levels compared to women
with BV (Balashov et al., 2014; Cox et al., 2015). Of note, primer
sets that target variable regions 1 and 2 of the gene encoding 16S
often see lower relative levels of Gardnerella in women with BV
when compared to studies that target variable regions 3 and/or
4 or that use culture-based studies (Graspeuntner et al., 2018).
It has been recently emphasized that 16S gene sequences cannot
differentiate the genetically divergent subsets of Gardnerella and
that other methods (e.g., cpn60 sequencing) are more effective in
this regard (Hill et al., 2019). Regardless of the method used to
detect Gardnerella in women, whether the organism is a causal
factor in BV cannot be determined by observational study. A
number of experimental studies in humans and other animals,
which we review here, have been conducted in an attempt to
address this question.
Methodology in brief: The purpose of this review is to
evaluate the experimental evidence for G. vaginalis as a causal
factor in generating the features or health complications that
have been associated with BV. Thus, in general, we sought to
focus on publications that had a similar experimental intent.
While this was not intended to be a systematic review, we
first searched PubMed using the search string: [(“Gardnerella”
or “Haemophilus vaginalis”) AND (“murine” OR “mouse” OR
“mice” OR “in vivo” OR “animal” OR “model”)]. Some papers,
especially older literature, could not be found using these specific
search terms. To find additional papers relevant to the topic,
we also carefully reviewed several published reviews on BV
and/or Gardnerella that addressed animal models (Catlin, 1992;
Turovskiy et al., 2011; Herbst-Kralovetz et al., 2016). Once the
papers were located, they were screened for inclusion in this
review based on the following criteria: (1) The papers were
available in English, (2) They described an in vivo inoculation
of G. vaginalis into the urogenital tract of an animal (including
humans), and (3) After inoculation, experimental hosts were
assessed for one or more features or health complications
previously associated with BV. Based on these criteria, we
excluded papers in which G. vaginalis was isolated from animals
but never experimentally inoculated, inoculation of G. vaginalis
was not into the urinary or reproductive tract, or the sole
intent was to introduce an intervention to eliminate G. vaginalis
colonization rather than to understand the causal or mechanistic
role of G. vaginalis interaction with the experimental host.
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EXPERIMENTAL STUDIES IN VIVO USING
Gardnerella ALONE
Vaginal Inoculation in Women
The earliest in vivo experiments using G. vaginalis were
performed in women with the intent of demonstrating “proof of
pathogenicity.” Gardner and Dukes suggested that G. vaginalis
could trigger “bacterial vaginitis” in otherwise healthy women.
Gardner and Dukes asserted that G. vaginalis was the sole
causative agent in most cases of the condition (Gardner and
Dukes, 1955). In their experimental infections, they vaginally
inoculated 13 healthy female volunteers with “pure cultures” of
several different strains ofG. vaginalis that had been isolated from
women with BV (although specific strains or culture conditions
were not reported, see Table 1). Of the inoculated women, 10 of
13 tested negative for G. vaginalis after inoculation. Two women
had positive cultures for G. vaginalis for 2–3 months, but showed
none of the clinical signs of NSV previously described by Gardner
and Dukes (vaginal pH >5, the presence of clue cells, thin
homogenous discharge, and a decrease in vaginal lactobacilli).
Only one of the 13 women was both culture-positive for G.
vaginalis and displayed clinical signs (Gardner and Dukes, 1955).
A second experiment was performed with 15 healthy female
volunteers, but the women were inoculated directly with vaginal
material from patients with NSV rather than cultured G.
vaginalis. This inoculation resulted in NSV signs in 11 of 15
women. In all of the patients that displayed clinical symptoms,
G. vaginalis was recovered by culture. Gardner and Dukes
attributed the low-incidence of vaginitis upon infection with
pure G. vaginalis cultures compared to direct inoculation with
vaginal material, to a loss of viability during serial passaging
of the bacteria (i.e., repeated culturing of the strain in the
laboratory) (Gardner and Dukes, 1955). However, looking back
from a modern perspective, these findings have other potential
explanations. For example, culture conditions are not stated and
viability of the inoculum used to infect women was not evaluated;
limited viability could have been due to growth phase rather than
serial passage. Alternatively, perhaps this was an early indication
that other organisms in addition to G. vaginalis may play a
role in BV. Consistent with the reproducible initiation of BV
by exposure to vaginal material (Gardner and Dukes, 1955),
a number of modern investigations have shown that specific
sexual practices that would result in a similar exposure to vaginal
material are linked with higher risks of BV, including the sharing
of sex toys between women who have sex with women (Bradshaw
et al., 2014; Olson et al., 2018; Muzny et al., 2019b).
Criswell et al. (1969) reported another attempt to induce NSV
in women via inoculation with pure cultures of G. vaginalis.
Twenty-nine pregnant volunteers were vaginally inoculated with
one of four different G. vaginalis strains (about 2 × 107 CFU),
which had been grown for either 12 or 24 h in liquid media. The
women were observed for development of NSV (referred to as
“H. vaginalis vaginitis”). Only two of the 20 subjects inoculated
with a 24-h culture of G. vaginalis developed symptoms, but
five of the nine women that were inoculated with a 12 h culture
showed clinical signs of H. vaginalis (see Table 1). The primary
conclusion by Criswell et al. was that these results confirmed
the earlier human experiments and hypotheses put forward by
Gardner and Dukes, namely that G. vaginalis infection alone
could trigger NSV. Their findings suggested that the age of the
inoculum affected the ability of G. vaginalis to colonize the host
resulting in clinical signs of NSV (Criswell et al., 1969). We will
explore this concept further in Section Discussion.
Vaginal Inoculation in Non-human Primates
In 1984, Johnson et al. published an attempt to model NSV in
non-human primates (Johnson et al., 1984) (see Table 1). Twelve
pig-tailed macaques, six tamarins, and four chimpanzees were
vaginally inoculated with one of four differentG. vaginalis strains.
These strains had been collected from women diagnosed with
NSV at a London clinic. The authors were unable to recover
G. vaginalis from any tamarins or chimpanzees 5–7 days after
inoculation. Only the pig-tailed macaques appeared susceptible
to colonization with the strain used in this setting, as all of the
inoculated animals remained culture-positive for G. vaginalis for
11–39 days. It was noted that the G. vaginalis strain used for
inoculation of chimpanzees was different than the one used in
macaques, and the former isolate had been extensively passaged
in the laboratory, whereas the latter had only been passaged
once. One of the two control macaques receiving PBS (vehicle
alone) had detectable G. vaginalis later in the experiment, which
the authors attributed to cross-contamination from a colonized
animal during vaginal washing (Johnson et al., 1984).
The authors examined the infected pig-tailed macaques for
clinical signs of NSV. No clue cells were observed in the
vaginal smears, regardless of whether the animal was successfully
colonized with G. vaginalis. Women with NSV had been
previously shown to exhibit higher vaginal pH and a higher ratio
of succinate to lactate compared to women without NSV (Amsel
et al., 1983). However, the authors also did not see an increase in
vaginal pH or higher succinate to lactate ratio in the colonized
animals. This may be explained by differences in vaginal
physiology and the endogenous microbes between humans
and macaques. Lactobacillus-dominant vaginal microbiomes in
women produce lactate, generating the characteristically low
vaginal pH (3.8–4.5) seen in most women (Boskey et al., 1999,
2001). The authors noted that compared to these “normal”
women, macaques at baseline already seemed to possess NSV-
like characteristics, including a high pH (6.0–7.0) and a high
succinate to lactate ratio (Johnson et al., 1984). The authors
also noted a high baseline vaginal pH in the chimpanzees (5.5–
6.0), and tamarins (7.0). These data suggest that non-human
primates have a fundamentally different composition of microbes
with different metabolic properties compared to women. More
recent studies using molecular approaches have confirmed that
macaque and other non-human primate vaginal microbiomes
typically reflect a scarcity of lactobacilli accompanied by diverse
microbial taxa, some of which are also found in human BV
(Uchihashi et al., 2015; Zhu et al., 2015; Obiero et al., 2016;
Miller et al., 2017). A 2010 study identified G. vaginalis via
16S sequencing in the vaginal microbiome of Rhesus macaques.
However,G. vaginaliswas found in only 2 of the 11macaques and





















TABLE 1 | Experimental studies of G. vaginalis infection in humans and other primates.



















N/A N/A N/A N/A Vaginal 15 11/15 11/15 positive for G.v. & clinical
signs: homogenous, odorous
discharge; pH>5.0









15 2/15 2/15 G.v. positive & clinical signs:
gray, thin, homogenous, odorous
discharge; pH >5.0, clue cells,
Gram neg rods in smears
G.v. 594 (ATCC
14018)
24 5 0/5 0/5 G.v. positive; no clinical signs
(as above)
12 9 5/9 5/9 G.v. positive & clinical signs
(as above)
Johnson et al., 1984 Pig-tailed
macaque
G.v. 584, 614 Peptone-starch-
dextrose broth +
10% horse serum
NR 24 5 × 106- 1 × 107 Intravaginal
(catheter or
pipette)
10 10/10 0/10 had clue cells; increased pH;
non-volatile fatty acids
Tamarin G.v. 584 3 × 106 4 0/4 0/4 had increased pH
Chimpanzee G.v. 812 and 958 Bordet-Gengou
agar
NR 48 5 × 107- 1 × 108 3 0/3 0/3 had clue cells; increased pH
Mårdh and Møller,
1984







48 2 × 109 Intravaginal
(swab)
8 2/8 Profuse, thin gray discharge
observed in 2/2 animals infected
with G.v. + LCR, 0/3
mono-infected animals. G.v.
recovered only from G.v. + LCR
infected animals. No clue cells,
increased odor, or elevated
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was present at relatively low levels—unlike the high abundance
and prevalence of G. vaginalis in human BV (Spear et al., 2010).
DNA as a Component of G. vaginalis
Biofilms
BV can be treated with antibiotics (most often metronidazole
and clindamycin) and antiseptics (e.g., dequalinium chloride)
(Mendling et al., 2016). However, though initially effective in
∼80% of cases, the rates of recurrence following antibiotic
treatment are extremely high; >50% of women will have
recurrent episode(s) within 6–12 months (Bradshaw and
Brotman, 2015). One proposed explanation for these high
rates of recurrence is the presence of G. vaginalis biofilms.
Dense biofilms containing G. vaginalis have been identified on
the vaginal epithelium of women with BV (Swidsinski et al.,
2005), and these biofilms can sometimes re-form after oral
metronidazole treatment (Swidsinski et al., 2008). In 2013,
Hymes et al. demonstrated in vitro that G. vaginalis biofilms
formed on polystyrene plates contain extracellular DNA. The
biofilms could be disrupted by DNase application, resulting in
a ∼5-fold reduction of bacterial titers measured in biofilms.
Furthermore, using a vaginal G. vaginalis infection model in
C57BL/6 mice, the authors also demonstrated that in vivoDNAse
treatment resulted in a >10-fold reduction in G. vaginalis titers
in the mouse vagina after 48 h (see Table 2 for comparison to
other rodent colonization models). However, the authors did not
evaluate whetherG. vaginalis forms biofilms in the mouse vagina,
and colonization density was low at 48 h, even in untreated mice
(Hymes et al., 2013). Other than the presence of G. vaginalis in
the vagina, this study did not examine or report the presence of
other features of BV.
Vaginal Infection With G. vaginalis in Mice
Results in Several Clinical Features of BV
In 2013, Gilbert et al. described a model of G. vaginalis vaginal
inoculation into C57BL/6 mice (6-8 weeks of age) using a
bacterial strain that had been recently isolated from a woman
with BV (see Table 2) (Gilbert et al., 2013). The mice were
treated with 17-β estradiol to bring them in proestrus, a technique
that had previously been used to model vaginal infection with
Neisseria gonorrhoeae (Jerse et al., 2011). G. vaginalis colonized
the mouse vagina and ascend into the uterine horns. G. vaginalis
titers in vaginal washes and vaginal homogenates were strongly
correlated, allowing for monitoring of G. vaginalis colonization
in vaginal washes prior to the study’s endpoint. Uterine and
vaginal titers were also significantly correlated, suggesting that
the degree of vaginal colonization was an important factor in
ascending infection by the bacterium. In addition to the presence
of G. vaginalis in vaginal fluid, several other BV-like features
were detected in the model. There was a strong correlation in
vaginal washes between the amount of live G. vaginalis and
levels of sialidase activity, an enzyme that has been used as
the basis for a point of care BV diagnostic test (Myziuk et al.,
2003; Bradshaw et al., 2005). Mice inoculated with G. vaginalis
also exhibited clue-like cells in vaginal washes, which were
confirmed to be coated with G. vaginalis that were fluorescently
labeled prior to inoculation. Although the literature often refers
to epithelial exfoliation as an explanation for the presence of
clue cells, this manuscript provided the first measurements
of exfoliated epithelial cells, both in the mouse model and
comparing women with and without BV. Significantly higher
levels of exfoliated cells were observed in animals infected with
G. vaginalis compared to mock-infected controls. Interaction
between G. vaginalis and mouse epithelial cells was visualized
by fluorescence microscopy (Figure 1). Likewise, women with
Nugent-defined BV had significantly higher levels of exfoliated
cells in Gram-stained slides compared to women without BV.
Finally, as in women, the G. vaginalis vaginal colonization did
not seem to induce classical signs of inflammation, as evidenced
by the lack of neutrophil infiltration or edema (Gilbert et al.,
2013). However, the lack of inflammation could also be a result
of estradiol administration.
Gardnerella vaginalis IN ASCENDING
INFECTION
G. vaginalis and other BV-associated bacteria are commonly
isolated from human endometrial, placental, intraamniotic and
perinatal infections (Berardi-Grassias et al., 1988; Hillier et al.,
1988; Silver et al., 1989; Watts et al., 1990; Gibbs, 1993;
Goldenberg et al., 1996; DiGiulio et al., 2010; DiGiulio, 2012;
Petrina et al., 2019). In this section, we examine the ability of G.
vaginalis to cause intrauterine infections after vaginal inoculation
or elicit health complications associated with ascending infection
during experimental infection.
Intrauterine Inoculation in Pregnant
Rabbits
Two studies have used a rabbit intrauterine infection model to
investigate the impact of G. vaginalis in the upper reproductive
tract during pregnancy (see Table 2). In this model, G. vaginalis
(strain ATCC14018) was transcervically administered directly
into each uterine horn by threading a cannula through the cervix
(Field et al., 1993). The stated goal of these experiments was to
determine if intrauterine infection by G. vaginalis would lead to
preterm birth, fetal abnormalities, or maternal morbidity. The
results indicated a significantly lower live-birth rate in the G.
vaginalis inoculated rabbits compared to the saline-inoculated
controls; however, there was not a greater incidence of preterm
birth among animals in the infected group. In 88% of the
infected animals, G. vaginalis could be detected in the amniotic
fluid. Additionally, the fetal and placental weights on the viable
fetuses were lower in the G. vaginalis infected group. The saline-
inoculated uterine horns did not appear inflamed, but clinical
signs of inflammation and histological deciduitis were observed
in the uterine horns that received G. vaginalis. There was also
significantly more evidence of neuropathology, including severe
brain injury, in the G. vaginalis exposed fetuses. From these
results, the authors conclude that G. vaginalis in the upper
reproductive tract has pathophysiological consequences for both
maternal and fetal tissues (Field et al., 1993).





















TABLE 2 | Experimental studies of G. vaginalis infection in rodent models.








Field et al., 1993 New Zealand & Calif.
White Rabbits
(pregnant)





17 N/A 17/17 G.v. deciduitis; 15/17 G.v.
intraamniotic infection; 10/17 severe
neuronal injury (0 in controls); 2/17
had preterm labor; infected group
had lower weight & high fetal mortality
McDuffie et al., 2002 New Zealand White
Rabbits
(pregnant)
G.v. NR NR NR NR 107 16 11/16 G.v intraamniotic (9/16), uterine
(11/16), blood (7/16), fetal brain
(10/16), fetal heart (6/16), and fetal
lung (8/16) infection.
Gilbert et al., 2013 C57BL/6 (inbred)
mice
G.v. JCP8151B NYC III Anaerobic
chamber
NR (16–18) 5 × 107 Intravaginal
(pipette)
39 36/39 Sialidase activity; epithelial exfoliation;
clue-like cells, mucus degradation,
uterine infection; absence of
histologic inflammatory response





NR 5% CO2 NR 5 × 106 Intravaginal
(5% gelatin)
10 10/10 DNase treatment reduced G.v. titers
>10-fold
Sierra et al., 2018 CD-1(outbred)
mice (pregnant)
G.v. ATCC14019 Tryptic Soy Broth +
5% Horse Serum







NR G.v. detected in cervicovaginal fluid;
increased cervical pro-inflammatory
cytokines; increased IL-6 in amniotic
fluid, cervical remodeling but no
increase in preterm birth
















31 23/31 (24hr) Sialidase activity; epithelial exfoliation;
increased vaginal P. bivia titers in
presence of G.v.; increased uterine
infection by P. bivia in presence of
G.v; absence of inflammatory
response













46 N/A G.v. exposure triggered exfoliation of
urothelial cells; emergence of E. coli
reservoirs; G.v. kidney infection,
kidney inflammation, more severe E.
coli kidney infections
Trinh et al., 2011 ICR (outbred)
mice









1.2 × 105 Intravaginal 6 NR Increased vaginal TNF-α, IL-1β, and
IL-6. Decreased IL-10. Increased
iNOS, COX-2, and myeloperoxidase
acitivity. Histological vaginal
inflammation
Joo et al., 2011 48 h 1 × 106 Increased vaginal TNF-α, IL-1β,
IL-17a, COX-2, iNOS, and
myeloperoxidase. Decreased IL-10.
Histological vaginal inflammation
Jang et al., 2017




NR 7 Increased TNF-α and
myeloperoxidase in vagina and
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FIGURE 1 | Gardnerella vaginalis (maroon) associated with the surface of a
mouse vaginal epithelial cell (purple). Epithelial cells were collected from
estrogenized mice by vaginal lavage with phosphate buffered saline. Epithelial
cells were centrifuged, washed three times to remove endogenous bacteria
then incubated for 4 h at 37◦C ex vivo with G. vaginalis strain JCP8151B.
Uranyl acetate staining was followed by transmission electron microscopy.
Photo credit: Wandy Beatty. This image illustrates how the use of a small
animal model can provide new resolution to aspects of BV that we appreciate,
but do not fully understand. The pictured interaction provides evidence that in
mice, as in women, G. vaginalis has an affinity with the vaginal epithelium.
More broadly, it also supports the use of mouse models in reflecting at least
some of the physiology we believe to occur in women.
Nearly a decade later, another study used the same
transvaginal cervical cannulation model of G. vaginalis infection
in pregnant rabbits (McDuffie et al., 2002). In this study, the
animals were sacrificed prior to parturition on days 4, 5, or 6 post-
inoculation, and a wide array of fetal and maternal tissues were
cultured to detect live G. vaginalis. G. vaginalis was detectable
(though titers were not reported) in the fetal brain, heart, and
lung of some infected animals, as well as in maternal blood,
uterine tissue, and amniotic fluid (see Table 2). Histological
evidence of fetal brain damage was greater in the infected group,
although the authors did not state whether the fetuses showing
signs of neuropathology were also those that had detectable G.
vaginalis titers in the brain. Additionally, the authors do not
report the strain of G. vaginalis used in this study, or from where
it was isolated (McDuffie et al., 2002). Of note, G. vaginalis has
been reported as a cause of bacteremia in pregnant women and
in at least one case, in a preterm neonate (Monif and Baer, 1976;
Venkataramani and Rathbun, 1976; Reimer and Reller, 1984;
Boggess et al., 1996; Agostini et al., 2003; Chen et al., 2018).
An important limitation of these two studies (Field et al.,
1993; McDuffie et al., 2002) was that they bypassed the normal
cervical barriers to ascending infection. As with many of the
experimental studies of G. vaginalis infection, this study used
a relatively high inoculum (see Tables 1, 2); it is unclear what
amount of G. vaginalis exposure to the upper reproductive tract
is physiologically relevant. It would have been informative if one
of these studies had included an experimental control group in
which “beneficial” vaginal bacteria (e.g., Lactobacillus crispatus)
were introduced in the same manner (transvaginal cervical
cannulation) to evaluate whether a non-pathogenic organism
would be culturable from tissues or stimulate maternal and fetal
immune responses when introduced in this manner. It is notable
that other BV bacteria (e.g., Prevotella bivia) have been delivered
using the same model, resulting in maternal fever and preterm
delivery in up to 33% of animals (Gibbs et al., 2004). Intrauterine,
intraperitoneal, or intravenous exposures to bacterial products
such as lipopolysaccharide (Gram negative bacteria) (Fidel et al.,
1998) or lipoteichoic acid (Gram positive bacteria) (Kajikawa
et al., 1998) have also been used as models of preterm birth in
pregnant mice.
Vaginal Inoculation of Gardnerella vaginalis
in Pregnant Mice Induces Cervical
Remodeling
BV has been linked to increased risk of preterm birth, although
the mechanisms linking such associations are still unclear (Svare
et al., 2006). Sierra et al. (2018) used a pregnant mouse model of
G. vaginalis infection to investigate the connection between BV
and preterm birth. Timed-pregnant CD-1 mice were vaginally
inoculated twice (on embryonic (E) days 12 and 13) with either
2.5 × 107 or 2.5 × 109 CFU of G. vaginalis. Animals were
then sacrificed 48 h after the second dose (E15) or allowed to
proceed to parturition. The authors did not observe a significant
increase in preterm birth (defined as delivery any day before
E18) in the G. vaginalis infected animals. There was also not
a significant difference in pup weight or litter size between
the control and infected animals. However, in those dams
sacrificed on E15, the authors observed signs of inflammation
and cervical remodeling following G. vaginalis inoculation. G.
vaginalis was found in the lower reproductive tract at sacrifice,
as determined by PCR. Although it is unclear what the detection
limit was in these experiments, the authors were unable to
detect the bacterium in the uterine horns, placenta, or fetal
membranes. Histology revealed increased mucicarmine staining
(interpreted as increased mucin, but other acidic glycans could
also explain this result). The authors conclude that increased
mucin production in pregnancy may reflect enhanced protection
against ascending infection. We note that the ATCC14018 strain
used in these experiments is negative for sialidase and does
not encode the genes recently shown to be responsible for
sialidase activity in cultured isolates (Robinson et al., 2019).
Thus, it is also possible that this strain lacks the ability to
cause ascending infection due to an inability to engage in
mucin degradation. There was a significant increase in IL-6
protein levels in the cervicovaginal fluid of infected animals as
compared to the controls. Interestingly, there was also increased
IL-6 in the amniotic fluid (AF) of infected animals, despite the
apparent lack of upper-reproductive tract colonization by G.
vaginalis. Infected mice also had increased soluble E-cadherin
in the cervicovaginal space, a biomarker of cervical epithelial
remodeling, and increased expression of Tff-1 gene (Sierra
et al., 2018), which is also thought to be important in the
remodeling process (Akgul et al., 2014). There was also increased
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transcript levels of the pro-inflammatory cytokines IL-8, IL-
1β, and IL-10 in the cervices of infected mice. The authors
also observed dispersion of collagen fibers in the cervices of
infected dams. Biomechanical testing showed that cervices of G.
vaginalis infected animals displayed significantly lower modulus
and higher maximum strain, but displayed no difference from
the control group in tissue cross sectional area, maximum
load, stiffness, or maximum stress. These data provide evidence
in support of the conclusion that cervical softening may be
“occurring faster/earlier” in response to G. vaginalis (Sierra et al.,
2018). While remodeling of the cervical epithelium is a normal
part of pregnancy as the body prepares for parturition (Timmons
et al., 2010), early induction of this remodeling by G. vaginalis
could contribute to preterm birth.
Gardnerella Infection and Vaginal
Inflammation
As previously discussed, there is some controversy surrounding
BV’s classification as an inflammatory or non-inflammatory
condition. Most cases of BV lack clinical signs of overt
inflammation such as swelling and redness (Mitchell and
Marrazzo, 2014), which seems at odds with studies that report
increased levels of inflammatory cytokines (Cauci et al., 2002,
2008; Hemalatha et al., 2012). To the best of our knowledge,
cytokine responses to G. vaginalis infection have not been
extensively studied using animal models. One exception is
the study just discussed by Sierra et al. in which authors
found elevated transcripts of several inflammatory cytokines
in G. vaginalis infected mice (Sierra et al., 2018). Another
notable exception is a group of studies published by a single
group, which investigate probiotic strategies to treat BV using
a mouse model of G. vaginalis infection (Joo et al., 2011; Trinh
et al., 2011; Jang et al., 2017; Kim et al., 2019). These studies
assessed immune markers of vaginal inflammation in response to
inoculation with G. vaginalis, to determine if these markers were
lower in animals receiving probiotics. These papers performed
intravaginal inoculation with the G. vaginalis strain KCTC5096
to model BV in β-estradiol treated mice (Joo et al., 2011; Trinh
et al., 2011; Jang et al., 2017) [note: bacterial strain not reported
in] (Kim et al., 2019). The mouse strains used were ICR in two of
the papers (Joo et al., 2011; Trinh et al., 2011), and C57Bl/6 in the
others (Jang et al., 2017; Kim et al., 2019).
Overall, all four studies report finding increased levels of
pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6
(determined by ELISA) in the vaginal tissue of infected mice as
compared to non-infected controls (Joo et al., 2011; Trinh et al.,
2011; Jang et al., 2017; Kim et al., 2019). The authors also reported
that IL-10, often regarded as an anti-inflammatory cytokine
(Couper et al., 2008), was consistently present at lower levels
in G. vaginalis infected mice compared to controls. In addition
to cytokines, the authors examined evidence of G. vaginalis-
induced inflammation by assessing myeloperoxidase, iNOS, and
COX-2 levels in the vaginal tissues of infected mice. The authors
report that mice inoculated with G. vaginalis had higher levels
of these inflammatory markers compared to uninfected controls.
Additionally, when histology was performed on vaginal tissue,
there appeared to be substantial edema and immune cell infiltrate
into the superficial mucosal layers (Joo et al., 2011; Trinh et al.,
2011).
A caveat to the findings of these studies is that some aspects
of the methodology are obscure. For example, it is not always
clear if the control group of uninfected mice were given β-
estradiol treatment. If they were not, it becomes impossible to
compare the infected vs. non-infected groups, as any differences
in inflammatory markers or histopathology could simply be
the result of only one group receiving hormone treatment.
Additionally, in at least one of the studies, the inocula of G.
vaginalis seems to be inconsistent between figures (Jang et al.,
2017). None of the data reported in these four publications show
individual data points to represent themice in each group and the
routine use of means and standard deviation might make these
data more sensitive to skewing by outliers. Finally, several of the
reported interpretations of increased vaginal inflammation rely
on immunoblots that were not quantified and histological images
that were not scored (Joo et al., 2011; Trinh et al., 2011; Jang et al.,
2017).
The question of BV and inflammation remains a tricky one.
Future in vivo studies aimed at untangling this mystery will need
to be rigorous about having appropriate controls and reporting
the data and methods in clear detail.
UNDERSTANDING HOW G. vaginalis MAY
INFLUENCE THE GROWTH OR
PATHOGENESIS OF OTHER BACTERIA
Despite Gardner and Dukes early assertions that Gardnerella
was the sole causative agent of BV, this is not a universally
accepted hypothesis (Hickey and Forney, 2014; Schwebke et al.,
2014a,b). Another hypothesis is that multiple species of bacteria
are needed to generate the features and complications that have
been associated with the condition (Muzny et al., 2019a). There
is also evidence, however, that G. vaginalis may still have a role
in the development of features that it does not directly cause,
and may do so by impacting the abundance or pathogenesis of
other organisms.
The Characteristic Fishy Odor of BV
Cannot Be Solely Attributed to G. vaginalis
In 1979 Chen et al. identified seven amines in the vaginal fluid
of women with BV (then NSV) that were absent in the fluid of
healthy controls. The authors theorized that these amines likely
contribute to the “fishy” odor associated with the condition,
and showed that the amines could be produced in vitro by the
vaginal bacteria isolated from NSV patients. However, while
these mixed vaginal communities were able to produce amines,
G. vaginalis isolates alone did not do so under the conditions
studied, suggesting that one of the major diagnostic features of
BV cannot be solely attributed to the presence of Gardnerella
(Chen et al., 1979). This finding is supported by a more recent
report from Nelson et al. (2015), which sought to identify the
vaginal bacteria capable of producing the BV-associated amines.
The authors looked for homologs of characterized biogenic
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amine-synthesizing proteins in the genomes of common vaginal
bacterial taxa. They found no evidence of any predicted genes
encoding biogenic amine-synthesizing proteins in the four G.
vaginalis strains they investigated (Nelson et al., 2015).
If G. vaginalis is unable to produce the amine species
characteristic of BV, then it is necessary to re-examine
interpretations from some of the first Gardnerella infection
models. The early human experiments by Criswell et al. (1969)
found that vaginal inoculation of pure G. vaginalis cultures could
replicate the clinical symptoms of “H. vaginalis vaginitis” as
described by Gardner and Dukes. These symptoms included the
“characteristic offensive odor” of the vaginal discharge (Criswell
et al., 1969). Assuming that the authors are describing the same
“fishy” odor as the Amsel criteria, this means that inoculation
with G. vaginalis was able to lead to the presence of various
amines in vaginal fluid. If G. vaginalis itself is unable to produce
these amines, this would suggest that colonization of the vaginal
tract by G. vaginalis also encourages the growth of amine-
producing bacterial species. Even at the time, Chen et al. (1979)
noted a possible symbiosis between G. vaginalis and amine-
producing bacteria, observing that while G. vaginalis cannot
produce amines in vitro, it does release large concentrations
of pyruvic acid and amino acids during growth. Conversely,
amino acids and pyruvic acid were depleted in the media of
the NSV mixed vaginal communities that were able to produce
amines, indicating the possibility that metabolites produced byG.
vaginalis can be consumed by amine-producing vaginal bacteria
(Chen et al., 1979).
Currently the BV field has identified several vaginal bacterial
taxa that have either been shown to produce amines in vitro or
have predicted amine-synthesizing proteins, including Prevotella,
Dialister, and Eggerthella species (Pybus and Onderdonk, 1997;
Nelson et al., 2015). Srinivasan et al. (2012) showed that the
presence of these taxa in the vaginal microbiome was associated
with the Whiff test, lending creed to their potential role as amine
producers. Notably, Srinivasan et al. (2012) also found that the
Whiff test was associated with the presence of G. vaginalis. This
finding seems to provide additional evidence to the possible
symbiosis between G. vaginalis and amine-producers in the
vaginal environment (Srinivasan et al., 2012).
G. vaginalis Encourages Ascending Uterine
Infection by Prevotella bivia in
Non-pregnant Mice
In 2019, Gilbert et al. described an estradiol-treated mouse co-
infection model with G. vaginalis and Prevotella bivia (Gilbert
et al., 2019). Prevotella species are prevalent in the vaginal
microbiome of women with BV (Srinivasan et al., 2012).
Additionally, like a number of other BV-associated organisms,
vaginal colonization by P. bivia has been linked to higher rates of
preterm birth (Krohn et al., 1991). In the reported model, both
G. vaginalis and P. bivia were able to colonize mouse vaginas
on their own, but co-inoculation with G. vaginalis led to higher
P. bivia vaginal titers 1-day post-infection, compared to animals
that were inoculated with P. bivia alone. Consistent with the idea
of reciprocal interactions between Gardnerella and Prevotella (as
discussed in section Interaction Between Gardnerella and Curved
Rods Generates Features of BV in Grivet Monkeys above), the
titers of the two organisms during vaginal colonization were
highly correlated (Spearman r = 0.9636). Additionally, P. bivia
titers in the uterine horns of co-infected animals were∼20 times
higher than in mono-infected animals at 2 days post-infection.
This finding suggests that G. vaginalis enhances the ability of P.
bivia to cause ascending infection of the reproductive tract. In
thismodel,G. vaginalis titers in the vagina and uterine horns were
not significantly different between mono and co-infected groups.
Consistent with the G. vaginalis inoculation model reported in
2013, no clinical signs of inflammation were observed in the
vaginas or uterine horns of mono or co-infected animals (Gilbert
et al., 2013, 2019).
Interaction Between Gardnerella and
Curved Rods Generates Features of BV in
Grivet Monkeys
In the 1980s it was reported that women with BV often
had motile, anaerobic curved rods (CR) in their vaginas.
In 1984, Mardh et al. vaginally inoculated grivet monkeys
with both G. vaginalis and CR isolates to determine if the
clinical features of BV could be replicated in a co-infection
primate model (see Table 1 for comparison to other human
and non-human primate experiments). This group used a short
morphotype (SCR) and long morphotype (LCR) (Mårdh and
Møller, 1984). While we cannot say for certain, it seems highly
likely that these CR morphotypes were in fact distinct species of
Mobiluncus that are commonly present in women with BV. Two
morphotypes of Mobiluncus can be distinguished by Gram-stain
examination: small (1.7 um) Gram-variable cells that correspond
to Mobiluncus curtisii and large (2.9 um) Gram-negative cells
that correspond to Mobiluncus mulieris (Dworkin et al., 2006).
Another possibility is that CR morphotypes on Gram stained
slides may be BVAB1 (a member of the family Lachnospiracea
and order Clostridiales) rather thanMobiluncus (Srinivasan et al.,
2013). However, given that modern microbiologists have not
yet succeeded in cultivating BVAB1, it seems more likely that
what was isolated and used in the Grivet monkey model was in
factMobiluncus.
In the Grivet model, G. vaginalis alone was unable to colonize,
as the authors could not recover it from the mono-infected
animals at 6 days post-infection. Conversely, both morphotypes
of CR could be isolated back out of mono or co-infected animals
for the entire 37-days observation period. One monkey that
had been inoculated with LCR was still culture positive after
9 months. However, no mono-infection with any of the three
organisms (SCR, LCR, or G. vaginalis) caused the animals to
develop any clinical signs of BV (clue cells, increased vaginal
discharge, or elevated vaginal pH). Co-infection with SCR and
G. vaginalis also did not yield any clinical signs of BV, and
while SCR could be recovered during the entire 37 days, G.
vaginalis was never re-isolated. However, animals that were co-
infected with G. vaginalis and LCR developed “profuse vaginal
discharge” that began 5 days after infection, which lasted through
the entire 37-days observation period. LCR could be isolated back
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out of the co-infected animals during the entire 37 days, and
G. vaginalis was recoverable until day 12. Co-infection with G.
vaginalis and LCR was the only condition in which G. vaginalis
was ever recoverable, and the only condition in which the profuse
discharge was observed. No clue cells or vaginal inflammation
were observed under any of the conditions (Mårdh and Møller,
1984).
G. vaginalis Triggers Kidney Injury and
Recurrent Urinary Tract Infection by
Escherichia coli
In addition to being present in the vagina, multiple studies
have isolated G. vaginalis from urine, including those that used
methods to collect urine that limit contamination by peri-
urethral and vaginal bacteria (e.g., suprapubic needle aspiration
or transurethral catheterization) (Pearce et al., 2014, 2015; Malki
et al., 2016; Thomas-White et al., 2016; Gottschick et al., 2017;
Kramer et al., 2018). Although most routine methods for urine
culture will not detect Gardnerella, studies that have used
appropriate isolation conditions suggest that the bladder is either
transiently exposed to G. vaginalis or that the organism may
colonize the bladder in some women [see Kline and Lewis (2016)
and references therein]. In one study, G. vaginalis was cultured
from (needle) aspirated urines from 20/33 (60%) patients
with chronic atrophic pyelonephritis (a.k.a. reflux neuropathy)
compared to only 2/35 healthy controls (9%) (Fairley and
Birch, 1983). Of 61 aspirates from men that were tested, none
yielded growth of G. vaginalis, while about 1/3 of women tested
had G. vaginalis in aspirated urine. Interestingly, women with
culture-positive (G. vaginalis, U. urealyticum, or other species)
aspirated urine also had squamous epithelial cells covered in
bacteria, bearing a close resemblance to clue cells seen in BV.
Another study of hospital inpatients reported that individuals
fromwhomGardnerellawas isolated from urine were more likely
to have a history of recurrent UTI and current pyelonephritis
(Josephson et al., 1988a). Together, these clinical data support
further investigations of the effects of Gardnerella in the
urinary tract.
Several reports suggest that women with BV are more
likely to experience UTI (Harmanli et al., 2000; Hillebrand
et al., 2002; Sharami et al., 2007; Sumati and Saritha, 2009;
Amatya et al., 2013; Gautam et al., 2015). One recent study
reported a mouse model to test the hypothesis that G. vaginalis
interactions with the bladder may contribute directly to the
association between BV and UTI (Gilbert et al., 2017). Mice
first received transurethral inoculation of Escherichia coli, the
most common cause of bladder and kidney infections. This
resulted in the formation of intracellular reservoirs that persist
following clearance of the bacteria from urine, as had been
shown previously (Mysorekar and Hultgren, 2006). Mice were
then inoculated twice with G. vaginalis. G. vaginalis did not
establish lasting colonization in the bladder, and nearly all mice
had undetectable titers by 12 h following exposure. However,
scanning electron microscopy and histological analysis of the
bladders, as well as urine cytology, revealed that even a
transient exposure to G. vaginalis induced urothelial exfoliation.
In the subsequent days following G. vaginalis exposure, E.
coli re-emerged from latent reservoirs back into the urine to
cause recurrent UTI that was accompanied by a neutrophilic
response. This phenotype was not observed when the mice were
transurethrally inoculated using identical methods in parallel,
with similar numbers of L. crispatus. This condition was used
to model bladder exposure to vaginal bacteria from a woman
without BV. Additionally, bladder exposure to G. vaginalis
increased the susceptibility of the mice to developing severe
(kidney and systemic) E. coli infections. This is consistent
with a clinical study which showed that kidney infection was
more common among female inpatients who had detectable
G. vaginalis in their urine (Josephson et al., 1988b). Gilbert
et al. (2017) also demonstrated that transurethral exposure to G.
vaginalis was sufficient to cause acute kidney injury that was a
direct result of inflammatory signaling via the IL-1 receptor and
occurred even in the absence of E. coli (Gilbert et al., 2017). These
findings, in conjunction with clinical data, suggest that further
investigation into the ability of G. vaginalis to induce urologic
pathology is necessary. As with the other models discussed above,
it will be interesting in future studies to learn if different species,
subspecies, or strains of Gardnerella (see more below) are able to
generate the different observed pathophysiologic features in the
urinary tract.
DISCUSSION
Taxonomic Diversity and Pathogenesis of
Gardnerella
Since the initial discovery of G. vaginalis (then H. vaginalis)
(Gardner and Dukes, 1954), many efforts have been made
to taxonomically sub-divide and identify isolates with the
greatest virulence potential (Piot et al., 1980, 1984; Pleckaityte
et al., 2012). Recent comparative genomic studies indicate
that G. vaginalis comprises at least four distinct phylogenetic
clades/subtypes (Ahmed et al., 2012; Malki et al., 2016). Recently,
one manuscript proposed a few new species names within
the genus Gardnerella (Vaneechoutte et al., 2019). However,
the broader clade designations contain multiple proposed
Gardnerella species, although names have only been proposed
for some. Regardless of the exact taxonomic scheme used, the
genomic diversity amongGardnerella isolates is substantial. Early
reports have suggested that the core genome shared by all G.
vaginalis isolates consists of only 25% of the total genes in the
G. vaginalis pangenome (Ahmed et al., 2012). The fact that
there are so many accessory genes among G. vaginalis clades
supports the hypothesis that the clades may occupy distinct
niches characterized by unique affiliations with other microbes,
communities, or host factors. Although different studies have not
always given consistent results, several clinical studies implicate
clade 1 and/or clade 2 strains in BV status, recurrence, and
other adverse outcomes linked with BV, such as preterm birth.
Conversely, clades 3 and 4 lack certain predicted virulence factors
and may be less pathogenic (Balashov et al., 2014; Callahan et al.,
2017; Hilbert et al., 2017; Goltsman et al., 2018; Janulaitiene et al.,
2018; Plummer et al., 2019). Interestingly, specific clades have
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also been linked with sexual practices. For example, one recent
study found that clade 1 was associated with higher numbers of
recent sexual partners while clade 2 was associated with penile-
vaginal intercourse and sharing of sex toys with female sex
partners (Plummer et al., 2019).
The earliest suggestions that women with BV may harbor
multiple subtypes of G. vaginalis came in 1990 when Briselden
and Hillier tested vaginal specimens for different “biotypes” of G.
vaginalis (Briselden and Hillier, 1990). Following the more recent
availability of genome sequences and clade definitions, several
literature reports have confirmed that multipleG. vaginalis clades
often co-exist in the vagina in women with BV (Balashov et al.,
2014; Janulaitiene et al., 2018; Plummer et al., 2019; Shipitsyna
et al., 2019). Because of this complexity, it is difficult based
on observations of clinical samples alone to make definitive
assertions about which clades may be involved in different
phenotypes or pathologies associated with BV.
Experimental models in animals (in the spirit of Koch’s
postulates) are needed to begin unraveling how each clade may
interact with the host, other organisms, and/or each other to
elicit features and health complications associated with BV. Clade
identifications are only available for some of the strains used
in previous experimental studies conducted to date. The most
common strains used in animal models have been ATCC14018
(clade 1) and JCP8151B (clade 2, now designated G. piotii), both
of which were sufficient to cause features and/or complications
linked with BV in human and animal models (see Tables 1, 2).
Some of the limitations of these models and their conclusions are
discussed in the paragraphs that follow.
Limitations of Animal Models
Mouse models of G. vaginalis infection have become much more
prevalent over the last decade and have shed light on a number
of interesting phenomena concerning G. vaginalis and BV.
However, there are clear limitations with these models. As with
the primate models, laboratory mice do not have a Lactobacillus
dominant microbiome. Therefore, it is not surprising that the
increase in vaginal pH associated with BV has not been achieved
in these models (Miller et al., 2016). Additionally, there are
likely to be differences in the endogenous vaginal microbiomes
depending on the strain of mouse and the facility where they
are raised. Differences in the mouse strain, housing conditions,
and/or vaginal microbiome could strongly impact susceptibility
and response to G. vaginalis infection. For example, Teixeira
et al. (2012) observed “inflammatory lesions” upon G. vaginalis
infection in their germ-free mice, while Gilbert et al. (2013, 2019)
have specifically noted a lack of inflammatory response in their
model using C57Bl/6 mice raised under conventional conditions
(Teixeira et al., 2012; Gilbert et al., 2013, 2019). Additionally,
many of the mouse models require β-estradiol administration to
bring mice into pro-estrus for the duration of the experiment
and avoid the PMN-rich post-ovulation period of the estrus
cycle (Gilbert et al., 2013). A potential limitation is that normal
immune responses to G. vaginalis infection may be altered by
the use of β-estradiol. Another potential limitation of mouse
models is that the vaginal epithelium is more highly keratinized
inmice (during pro-estrus) than in humans, whichmay influence
the normal course of G. vaginalis infection (Sierra et al., 2018).
Finally, previous work had shown that the G. vaginalis toxin
vaginolysin (a cholesterol-dependent cytolysin) is species-specific
and requires the presence of human CD59 (Gelber et al., 2008).
It is not clear whether this finding applies to other primate
models, but nevertheless, the development of a humanizedmouse
expressing human CD59 might improve the G. vaginalis mouse
infection model. Perhaps the biggest limitation of experimental
studies in humans or animals is that they rarely consider that
the presence of the endogenous vaginal microbiome is likely
to discourage colonization by exogenous organisms that are
introduced, a phenomenon known as colonization resistance.
The use of non-human primates in research presents additional
challenges, expense, and ethical considerations, but may be
worthwhile to better understand the microbial ecology and
interactions with the host mucosa in BV. It has been noted
that the vaginal microbiomes of many of the species of non-
human primates for whom such studies have been performed
have communities that resemble BV (Uchihashi et al., 2015; Zhu
et al., 2015; Obiero et al., 2016; Miller et al., 2017). Thus, while
there are greater obstacles to their use, nonhuman primates may
also offer important advantages over other model systems.
Ethics of Human Experimentation
When the early human infections with G. vaginalis were
performed, the experimenters had little understanding of the
pathology of BV. The risks and adverse health outcomes
associated with BV were unknown at the time, and the condition
was thought to be relatively benign. Indeed, in their hallmark
1955 paper, Gardner and Dukes express their belief that BV is
“physically and esthetically objectionable,” but that “the disease is
not a serious one.” Additionally, they wrote that “therapeutically,
[BV] constitute[s] no difficult problem” (Gardner and Dukes,
1955) which is in clear contrast to more recent literature on the
difficulty treating BV and the high rates recurrence (Bradshaw
and Brotman, 2015). This erroneous belief in the banality of
BV explains how groups in the 1950s and 60s were comfortable
performing vaginal inoculations of G. vaginalis into women
(Gardner and Dukes, 1955; Criswell et al., 1969). In light of
our current understanding, it can be clearly argued that these
experiments represented an unacceptable risk for the subjects
that in today’s scientific environment would need to be clearly
articulated during informed consent and could result in outright
rejection by institutional review boards. While these early papers
provide useful insight into G. vaginalis and BV, their ethical
dubiousness also act as a cautionary tale in the dangers of
misguided assumptions in the pursuit of further understanding.
This lesson is an important one to remember, especially
considering that human experimentation in BV research still
occurs today. Now however, the experiments are aimed at
directly treating BV and improving quality of life for those
women afflicted. In 2019 Lev-Sagie et al. reported the first
vaginal microbiome transplantation (VMT) performed in human
women. The transplants were from three BV-negative donors
with Lactobacillus crispatus-dominated vaginal microbiomes.
The five recipients were women with intractable BV who
experienced recurrent symptomatic episodes, despite antibiotic
treatment, and so were good candidates for alternative therapy.
The recipients all received antibiotic treatment for 5–7 days
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immediately prior to the first VMT. Vaginal discharge from
the donors was collected and introduced into the recipients,
and the recipients received clinical follow-up to assess BV
symptoms for 5–21 months following VMT. Four of the five
recipients experienced full long-term remission (defined as
absence of symptoms, an Amsel score of 0, and the presence of a
Lactobacillus dominated microbiome), although three of the four
required multiple rounds of VMT. The fifth woman experienced
partial symptom improvement, although her vaginal microbiome
was not lactobacilli-dominated at the end of the observation
period (Lev-Sagie et al., 2019).
These results overall appear promising, and unlike in the
human experiments of the 1950s and 60s, the authors of this
study carefully screened donors for STIs and other important
infections such as hepatitis and cytomegalovirus. However, the
authors themselves also acknowledge that there is always the
possibility of unforeseen risk with VMT—after all, we still know
relatively little about the vast majority of the microbes that live in
this niche. For this reason, Lev-Sagie et al. emphasize that VMT
should be considered only as a last resort for intractable BVwhere
quality of life is severely disrupted andmultiple treatment options
have failed (Lev-Sagie et al., 2019).
Finally, we note the need for consistency in diagnostic terms
for BV that are used by academia and industry as well as the need
to provide specific methods used to define such diagnoses.
Have Koch’s Postulates Been Satisfied
That G. vaginalis Is a Cause of BV?
Koch’s original postulates established a microorganism is the
cause of a disease if it was (1) found in all diseased, but not healthy
individuals, (2) could be isolated and grown in pure culture,
(3) caused disease when introduced into an experimental host,
and (4) could be re-isolated and re-identified from the infected
experimental host. Of course, arguments have been advanced
by Koch himself, and many others since, in favor of revising
the original postulates for biological and technical reasons as
it became clear that they were too rigid in their original form
(see below).
Is Gardnerella Found in All Cases of NSV/BV but Not
Among Healthy Women?
Over the years, scientists have used different methods to detect
and identify Gardnerella and different criteria to define BV,
leading to somewhat different conclusions. In the first published
studies, Gardner and Dukes found that G. vaginalis was detected
in >90% of women with clinical signs we now recognize as BV,
but never in apparently healthy control women (Gardner and
Dukes, 1955). By the 1980’s, the use of human blood bilayermedia
and other culture techniques had improved the ability to culture
“Gardnerella” and led to a higher proportion of “normal” women
appearing positive for Gardnerella (Totten et al., 1982; Hillier,
1993). However, culture-based studies in the 1980s and more
recent quantitative PCR methods seem to agree that Gardnerella
is found at orders of magnitude higher levels in women with BV
compared to those without the condition (Sheiness et al., 1992;
Balashov et al., 2014). This first of Koch’s postulates has been
modified for causative agents of some bacterial infections in light
of findings that they can be harbored by a subset of individuals
without causing symptoms or harm (e.g.,Haemophilus influenza,
Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus
agalactiae, etc.) (Fredricks and Relman, 1996; Duell et al., 2016;
Krismer et al., 2017; Shabayek and Spellerberg, 2018;Weiser et al.,
2018). In fact, Koch himself realized this upon the discovery
that some individuals carried the causative agents of cholera and
typhoid without apparent signs of disease (Evans, 1976). Thus,
it is also possible that carrier states may exist for Gardnerella.
Two alternate explanations for the presence of Gardnerella in
women without BV could be that the strains in question may
have fewer virulence factors (see the section above onGardnerella
taxonomy) or are kept “in check” by strains of beneficial bacteria
with particularly powerful antimicrobial activities.
Can Gardnerella Be Isolated in Pure Culture and
Re-Isolated From Infected Hosts?
Since its original description in the 1950s, the isolation and
growth of Gardnerella in culture has been reported using several
methodologies, including different culture media (see Tables 1,
2) and use of different atmospheric conditions (anaerobic, 5%
CO2). Broadly speaking, it is not known whether the reported
culture conditions for preparing G. vaginalis inocula used in
experimental studies result in expression of the factors needed for
colonization/infection. Experimental studies in humans (Criswell
et al., 1969), primates (Mårdh and Møller, 1984), and mice
(Gilbert et al., 2013) showed that when signs of BV were present,
G. vaginalis was recoverable. One exception to this was the
finding in pig-tailed macaques that G. vaginalis was recoverable
from 10/10 inoculated individuals but did not result in the
appearance of clue cells, more basic pH, or change in non-volatile
acids (Johnson et al., 1984). As discussed elsewhere, based on the
absence of dominant lactobacilli in these animals, it is arguable
that the latter two signs may not be possible to generate in
this system.
Can Gardnerella Reproduce Features of BV in
Experimental Models?
Only two studies in the literature inoculated Gardnerella into
human volunteers. Although the first experiments from Gardner
and Dukes (1955) claimed “proof of pathogenicity,” these studies
provide little evidence for this conclusion (see Section Vaginal
Inoculation in Women) (Gardner and Dukes, 1955). It is hard to
know what the authors did in these experiments since they report
no detailed culture conditions or bacterial strain names. There
was not a control group of women left uninoculated to determine
if women might spontaneously develop signs of BV or become
colonized with Gardnerella.
The second of the two experimental studies performed in
humans was also performed by Gardner and Dukes, but involved
another co-author (Criswell). One of the interesting questions
evaluated by Criswell et al. (1969) was whether Gardnerella
strains grown in culture for 12 or 24 h resulted in clinical signs
of BV when “poured” into the vaginas of 29 women. About half
of these women were inoculated with the strain ATCC14018,
which caused clinical signs of BV in most of the women when
the inoculum was prepared from a 12-h culture. In contrast,
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the same strain grown for 24-h did not cause signs of BV in
any of the inoculated individuals. Three other strains were used
in this paper to inoculate another 15 women. Although clade
designation of these strains is not known, 24-h cultures were
used and only two of fifteen women were found to have signs
of BV (Criswell et al., 1969). Although statistical analysis was
not presented by the authors, our analysis of results from the
29 women inoculated shows that those receiving 12 h cultures
were significantly more likely to develop signs of BV compared
to those who received 24 h cultures (Figure 2). This raises the
question of whether 24 h cultures of Gardnerella under the
conditions used were viable for colonization.
Later studies that investigated signs of BV in primates
inoculated with Gardnerella did not provide substantial evidence
in support of Gardnerella as a causal factor in the development
of BV, but had several important limitations. First, none of the
strains used have survived to the present day so we cannot use
molecular techniques to confirm their identity as G. vaginalis
or determine to what clade they belong. Additionally, it is not
always clear how the bacteria were cultured for preparation of
the inoculum (medium or atmospheric conditions used were
not fully reported). The Johnson et al. (1984) and Mårdh and
Møller (1984) studies report using older cultures of Gardnerella
(24 or 48 hour cultures) (Johnson et al., 1984; Mårdh and Møller,
1984). As stated above, although “increased pH” was one of the
main foci of the investigations, the primates used in these studies
typically already have more neutral vaginal pH at baseline (before
inoculation). Thus, it may not be possible to make the vaginas
of these animals more basic. Later studies have illustrated that
non-human primates harbor microbiomes that contain diverse
taxa and typically are not characterized by dominant lactobacilli
(Stumpf et al., 2013). With that said, it is not always clear how
interactions with humans may change the landscape of wild
microbiomes, as recent studies in mice have revealed (Rosshart
et al., 2017). It is noteworthy that 10/10 pig-tailed macaques
developed colonization with Gardnerella in the Johnson et al.
(1984) study, but did not develop signs of BV (Johnson et al.,
FIGURE 2 | Data from Criswell et al. (1969) plotted and analyzed to evaluate
statistical difference between ability of 12 h vs. 24 h G. vaginalis cultures to
cause signs of BV when inoculated into women.
1984). But, as we do not know what taxonomic lineage the strains
used in this study belong to, the lack of BV signs could also reflect
a less virulent isolate was used.
We argue that the most definitive conclusions regarding
whether G. vaginalis experimental administration reproduces
features and complications associated with BV in women can
be derived from experiments performed using three strains:
ATCC14018, ATCC14019, and JCP8151B. Experimental studies
performed using the clade 1 strain ATCC14018 showed that
this strain yielded clinical signs of BV in 5/9 women when
12-h cultures were used for inoculation (Criswell et al., 1969)
(see Figure 2). More than four decades later, one study may
have provided an explanation by showing that extracellular
DNA produced by G. vaginalis contributes importantly to the
production of biofilms and is only present in the cell-free
supernatant of early cultures (Hymes et al., 2013). Another G.
vaginalis clade 1 strain, ATCC14019 was originally isolated by
Gardner and Dukes and is nearly identical in genome sequence
to ATCC14018. Administration of ATCC14019 vaginally into
pregnant mice resulted in evidence of cervical remodeling and
increased IL-6 in the vagina and amniotic fluid (Sierra et al.,
2018), consistent with findings of elevated IL-6 in women with
BV (Yudin et al., 2003; Campos et al., 2012) and associations of
clade1/2G. vaginaliswith preterm birth (Callahan et al., 2017). In
another mouse model, the clade 2 strain JCP8151B was shown to
result in colonization and live recovery of Gardnerella, clue-like
cells with adherentGardnerella, an epithelial exfoliation response
similar to that seen in humans, and higher levels of the hydrolytic
enzyme sialidase together with biochemical evidence of mucus
degradation, similar to that seen in BV (Gilbert et al., 2013;
Lewis et al., 2013). The recent suggestions for new species names
for subsets of Gardnerella strains seems to place the JCP8151B
strain within the subset of clade 2 strains being referred to as
Gardnerella piotii (Hill et al., 2019; Vaneechoutte et al., 2019). In
short, the experimental evidence points to the conclusion that G.
vaginalis and G. piotii (if this naming scheme is adopted by the
field) can cause clinical signs of BV when introduced into human
and animal hosts.
Can Gardnerella Influence the Pathogenesis of Other
Organisms in Experimental Models?
Women with BV appear to be more susceptible to a wide
variety of other infections, including infections of the lower
reproductive tract (Brotman et al., 2010), the upper reproductive
tract (Ádám et al., 2018), and the nearby urinary tract (Harmanli
et al., 2000). However, we still know relatively little about
which organisms in BV might confer these increased risks or
the mechanisms leading to disease. In addition to findings
that certain strains of Gardnerella can reproduce features
of BV in experimental models, there is also evidence to
support the conclusion that Gardnerella can influence whether
other organisms cause pathophysiology. Specifically, vaginal
colonization by the JCP8151B strain caused mice to experience
higher titer ascending uterine infections by Prevotella bivia
compared to animals that received only P. bivia (Gilbert et al.,
2019). The JCP8151B strain was also able to trigger recurrent
UTI caused by uropathogenic E. coli that re-emerged from long
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lasting reservoirs inside epithelial cells in response to bladder
exposure to Gardnerella, but not Lactobacillus crispatus (Gilbert
et al., 2017).
In conclusion, we have only scratched the surface in
understanding how microbes coordinate the biological processes
that initiate and perpetuate BV. Nevertheless, experimental
models have given us key insights into the causal relationship
of Gardnerella with BV. Together, the studies reviewed here
suggest that Gardnerella vaginalis can, under some conditions,
recreate some of the features and complications that have been
associated with BV. Although we do not yet understand the
precise molecular mechanisms, additional experimental studies
suggest that Gardnerella vaginalismay change the host landscape
in a way that makes other organisms more likely to colonize
or cause disease. Future studies should expand and optimize
small animal models to further refine our understanding of how
species, subspecies, and strains of BV bacteria act alone and in
concert with other microbes to overcome the healthy microflora
and lead to poor health outcomes.
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